| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.03. | CLEARBRIDGE HEALTH LIMITED: RESPONSE TO SGX QUERIES | 3 | SGX Company Announcements | ||
| 27.02. | CLEARBRIDGE HEALTH LIMITED: ASSET ACQUISITIONS AND DISPOSALS::ANNOUNCEMENT PURSUANT TO RULE 706A OF THE CATALIST RULES | 1 | SGX Company Announcements | ||
| 27.02. | CLEARBRIDGE HEALTH LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS | 1 | SGX Company Announcements | ||
| CLEARBRIDGE HEALTH Aktie jetzt für 0€ handeln | |||||
| 23.02. | CLEARBRIDGE HEALTH LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::PROFIT GUIDANCE | 1 | SGX Company Announcements | ||
| 06.02. | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::CHANGES IN COMPOSITION OF THE REMUNERATION COMMITTEE | 2 | SGX Company Announcements | ||
| 06.02. | CLEARBRIDGE HEALTH LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::RESIGNATION OF NON-EXECUTIVE NON-INDEPENDENT CHAIRMAN - MR. CHEN JOHNSON | 1 | SGX Company Announcements | ||
| 23.01. | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::LAPSE OF TERM SHEET IN RELATION TO THE PROPOSED ACQUISITION OF ELPIS BIOPHARMACEUTICALS PTE. LTD. | 1 | SGX Company Announcements | ||
| 13.11.25 | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::USE OF PROCEEDS FROM THE PLACEMENT | - | SGX Company Announcements | ||
| 03.11.25 | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::CLEARBRIDGE HEALTH COMMENCEMENT OF ADULT IMMUNE CELL BANKING BUSINESS | - | SGX Company Announcements | ||
| 06.10.25 | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::EXTENSION OF CONVERTIBLE BOND MATURITY DATE | 2 | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 37,110 | +0,32 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Niedrigere Schätzungen hätten die Kurse in... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,860 | -1,07 % | DZ BANK stuft FMC FRESENIUS MEDICAL CARE AG auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für FMC mit einem fairen Aktienwert von 56 Euro auf "Kaufen" belassen. Die Transformation des Dialyse-Anbieters sei abgeschlossen, nun könne... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 44,010 | 0,00 % | Leerink reiterates Outperform on BrightSpring Health stock after investor day | ||
| FRESENIUS | 44,640 | +0,31 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - JPMorgan hat das Kursziel für Fresenius von 53,60 auf 56,60 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Aktie bleibt zudem auf der "Analyst Focus List"... ► Artikel lesen | |
| HEARTFLOW | 25,870 | 0,00 % | Heartflow stock price target raised to $43 by Canaccord on guidance | ||
| ALIGNMENT HEALTHCARE | 18,160 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| GENEDX | 72,97 | 0,00 % | Jefferies reiterates GeneDx stock rating citing data advantage | ||
| GUARDIAN PHARMACY SERVICES | 34,420 | 0,00 % | Guardian Pharmacy prices $186M upsized offering at $31 per share | ||
| AVEANNA HEALTHCARE | 6,320 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Fourth Quarter and Full Year 2025 Financial Results | Fourth Quarter Revenue was $662.5 million, a 27.4% increase over the prior year periodFourth Quarter Net income was $178.8 million compared to $29.2 million for the prior year periodAdjusted EBITDA... ► Artikel lesen | |
| PROGYNY | 18,190 | 0,00 % | Barclays cuts Progyny stock price target on membership concerns | ||
| PROCEPT BIOROBOTICS | 25,670 | 0,00 % | PROCEPT BioRobotics Announces International Launch of the HYDROS Robotic System, Expanding Global Access to AI-Enabled Aquablation Therapy | UK marks first international launch of the HYDROS Robotic System, with additional international expansion planned in 2026SAN JOSE, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq:... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 23,200 | -1,61 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 28,50 Euro auf "Market-Perform" belassen. Die europäische Medizintechnikbranche... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,300 | +1,27 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 3,545 | 0,00 % | Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | ||
| BRAINSWAY | 13,930 | 0,00 % | BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health | BURLINGTON, Mass. and JERUSALEM, March 19, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments... ► Artikel lesen |